A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT02635204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days
Study identification
- NCT ID
- NCT02635204
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Promius Pharma, LLC
- Industry
- Enrollment
- 267 participants
Conditions and interventions
Conditions
Interventions
- DFD06 Cream Drug
- Vehicle Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Jun 30, 2016
- Completion
- Jun 30, 2016
- Last update posted
- May 14, 2018
2015 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 116 | Glendale | Arizona | 85308 | — |
| Site 111 | Rogers | Arkansas | 72758 | — |
| Site 124 | Fountain Valley | California | 92708 | — |
| Site 120 | Laguna Hills | California | 92653 | — |
| Site 122 | San Diego | California | 92108 | — |
| Site 123 | San Diego | California | 92123 | — |
| Site 113 | Denver | Colorado | 80220 | — |
| Site 117 | New Haven | Connecticut | 06511 | — |
| Site 108 | Brandon | Florida | 33511 | — |
| Site 112 | Coral Gables | Florida | 33134 | — |
| Site 106 | Jacksonville | Florida | 32204 | — |
| Site 110 | Pinellas Park | Florida | 33781 | — |
| 130 | West Palm Beach | Florida | 33406 | — |
| Site 103 | Arlington Heights | Illinois | 60005 | — |
| Site 115 | Overland Park | Kansas | 66215 | — |
| Site 127 | Beverly | Massachusetts | 01915 | — |
| Site 119 | Quincy | Massachusetts | 02169 | — |
| 129 | Henderson | Nevada | 89052 | — |
| Site 114 | New York | New York | 10019 | — |
| Site 104 | Rocky Mount | North Carolina | 27804 | — |
| Site 105 | Wilmington | North Carolina | 28401 | — |
| Site 126 | Cincinnati | Ohio | 45255 | — |
| Site 121 | Warwick | Rhode Island | 02886 | — |
| Site 107 | Nashville | Tennessee | 37215 | — |
| 128 | Arlington | Texas | 76014 | — |
| Site 101 | Dallas | Texas | 75234 | — |
| Site 102 | Houston | Texas | 77056 | — |
| Site 109 | San Antonio | Texas | 78229 | — |
| Site 118 | Norfolk | Virginia | 23507 | — |
| Site 125 | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02635204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02635204 live on ClinicalTrials.gov.